MyGenome
MyGenome provides molecular genomic tests for individuals to assess disease risk and enable precision medicine.
mygenome.asia/Industry
Healthcare > Biotechnology
Company Type
Product-Led Startup/Scaleup
Technology
Next Generation Sequencing (NGS)
Digital Gene Platform
Real-Time PCR
Standard PCR
Microarray
Liquid Biopsy
Bioinformatics
About MyGenome
MyGenome Sdn. Bhd. is a biotechnology company specializing in precision medicine. The company offers in-house molecular genomic tests, including Next Generation Sequencing (NGS) and PCR techniques, for genetic profiling. Their services assess disease risks for various conditions like cancers, cardiac, metabolic, and neurogenetic diseases, supporting preventive medicine and personalized health strategies. MyGenome also conducts microbial product testing and in vitro drug interaction studies.
Founded
2018
Company Age
8 years
Location
KUALA LUMPUR, Kuala Lumpur
Malaysia
Company Size
2-10 employees